Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Statins in Patients With CCUS and MDS
NCT05483010Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2024
- Primary completion
- May 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin, rosuvastatin in clonal cytopenia of undetermined significance (CCUS), myelodysplastic syndrome (MDS), sponsored by Washington University School of Medicine. Started Feb 2024; status: recruiting.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
clonal cytopenia of undetermined significance (CCUS)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT05483010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05483010.